What Is Stage 1 Mesothelioma?
Stage 1 mesothelioma is the earliest stage of the disease, meaning the cancer is confined to the pleural lining on one side of the chest and has not spread to lymph nodes or distant organs. Patients diagnosed at this stage have the best prognosis and the widest range of treatment options, including potentially curative surgery.
Stage 1A vs. Stage 1B
Stage 1 pleural mesothelioma is divided into two substages based on how much of the pleural lining is affected. In Stage 1A, the tumor is limited to the parietal pleura — the outer layer that lines the chest wall — on one side of the chest. The visceral pleura (the inner layer that covers the lungs) is not involved, and there is no spread to lymph nodes or distant organs.
In Stage 1B, the cancer has grown to involve both the parietal and visceral pleura on one side. While the tumor is still localized, the involvement of both pleural layers represents slightly more advanced disease. Both Stage 1A and 1B are considered early-stage and carry the most favorable prognosis among all mesothelioma stages.
Accurately determining the substage requires imaging studies such as CT scans and often surgical evaluation, as the distinction between 1A and 1B can be difficult to determine through imaging alone.
Symptoms at Stage 1
One of the challenges with Stage 1 mesothelioma is that symptoms are often mild, nonspecific, or entirely absent. When present, early symptoms may include occasional chest discomfort, mild shortness of breath during exertion, or a persistent dry cough. These symptoms are easily attributed to more common conditions such as pneumonia, bronchitis, or age-related respiratory changes.
Because of the subtle nature of early symptoms and the disease's long latency period following asbestos exposure, Stage 1 diagnoses are relatively uncommon. Many Stage 1 cases are discovered incidentally during imaging studies performed for other medical reasons.
Treatment Options for Stage 1
Stage 1 mesothelioma patients generally have the most treatment options available. Surgical resection is typically the cornerstone of treatment, with the goal of removing as much visible tumor as possible. Two primary surgical approaches are used:
Pleurectomy/decortication (P/D) removes the affected pleural lining while preserving the lung. This is the preferred approach for many Stage 1 patients because it maintains lung function and has lower surgical mortality. Extrapleural pneumonectomy (EPP) removes the affected pleura, the lung on that side, part of the diaphragm, and the pericardium. EPP is a more radical procedure reserved for select patients who can tolerate the more extensive surgery.
Surgery is typically combined with chemotherapy (usually a pemetrexed and cisplatin regimen) and, in some cases, radiation therapy. This multimodal approach has been shown to provide the best outcomes for early-stage patients.
Prognosis and Survival
Stage 1 mesothelioma carries the most favorable prognosis of all stages. Median survival with treatment ranges from approximately 21 to 40 months, depending on the cell type, the patient's overall health, and the specific treatment approach. Patients with epithelioid cell type who undergo successful surgical resection tend to have the longest survival times, with some studies reporting 5-year survival rates above 15–20%.
Prognosis also depends on factors beyond staging, including the patient's age, performance status, and response to initial treatment. Working with a medical team experienced in mesothelioma treatment is essential for optimizing outcomes at any stage.
Legal Rights After a Stage 1 Diagnosis
A Stage 1 mesothelioma diagnosis does not diminish your legal rights. Regardless of the stage, every person diagnosed with mesothelioma caused by asbestos exposure has the right to pursue compensation. In fact, an early-stage diagnosis may provide additional time to build a thorough legal case. Contact an experienced mesothelioma attorney to discuss your options as soon as possible after diagnosis.
- Definition: Cancer confined to the pleural lining on one side
- Substages: 1A (one pleural layer) and 1B (both pleural layers)
- Lymph nodes: Not involved
- Median survival: 21–40 months with treatment
- Surgery: Most patients are candidates for surgical intervention
Reviewed by: Paul Danziger, J.D. — Texas Bar — 30+ years mesothelioma litigation
Last updated: March 15, 2026
Sources: American Cancer Society, National Cancer Institute, National Comprehensive Cancer Network
Our attorneys have handled mesothelioma cases for over 30 years. We can evaluate your situation, explain every option available to you, and answer your questions — all at no cost and with no obligation.
Request a Free Consultation
Your information is confidential and protected. We typically respond within 24 hours.
Call 1-800-400-1805 for immediate help.